AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Pelagos Insurance Capital, you need to be comfortable with a specialty insurer that couples underwriting-focused earnings with active capital returns. The key near term catalyst is whether the earnings recovery can hold up despite catastrophe losses, while the biggest risk remains that large events and pricing pressure could quickly squeeze margins. The latest results and buyback completion support the existing story but do not remove that underlying risk.
The most relevant update here is Pelagos completing the repurchase of about one third of its shares for US$430.1 million. Against a backdrop of Pelagos returning to profit in the first half of 2026, this materially lifts earnings per share and book value per share sensitivity for remaining shareholders, which can cut both ways if catastrophe volatility or adverse loss development hits future results.
Yet investors should also weigh how Pelagos’s exposure to catastrophe heavy lines could magnify the next period of elevated losses and what that might mean for...
Read the full narrative on Pelagos Insurance Capital (it's free!)
Pelagos Insurance Capital's narrative projects $3.2 billion revenue and $348.2 million earnings by 2029. This requires 9.8% yearly revenue growth and a $27.8 million earnings decrease from $376.0 million.
Uncover how Pelagos Insurance Capital's forecasts yield a $25.72 fair value, a 9% upside to its current price.
Before this quarter, the most pessimistic analysts assumed Pelagos earnings would fall toward about US$365 million even as revenues climbed to roughly US$3.5 billion, so you may find it helpful to compare those cautious expectations with the latest results and your own view on catastrophe risk.
Explore 3 other fair value estimates on Pelagos Insurance Capital - why the stock might be worth over 3x more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com